TL;DR
This paper investigates how the transcription factor N-myc forms dynamic condensates through phase separation, and how this process impacts gene expression. They developed a novel chemogenetic tool to precisely control N-myc phase separation, revealing that while N-myc condensates are transcriptionally active, only a small subset of genes are differentially regulated by phase separation compared to diffuse N-myc.
What Problem Does This Paper Address?
The MYC family of transcription factors, including MYC and MYCN, are frequently dysregulated in human cancers, particularly neuroblastoma where MYCN is amplified. High levels of N-myc drive proliferation and cell survival by activating specific genes. However, it's unclear whether this enhanced activity is due to N-myc binding to more low-affinity sites in the genome or a fundamental change in its activation mechanism. One proposed mechanism for this change is the formation of "transcriptional condensates" through phase separation, a process where proteins spontaneously assemble into dense, liquid-like droplets above a certain concentration. While phase separation is increasingly linked to gene regulation, its specific contribution to N-myc's oncogenic function and how it alters transcriptional output remains poorly understood. This paper aims to dissect the role of N-myc phase separation in gene regulation and its functional consequences.
Methods
The researchers employed a multi-pronged approach:
- Immunofluorescence Microscopy: To visualize N-myc localization and condensate formation in both MYCN-amplified (Kelly) and MYCN-nonamplified (SH-EP) neuroblastoma cells.
- Live-Cell Imaging: To observe the dynamic behavior of N-myc condensates, including their formation, fusion, and disassembly during mitosis.
- Chemogenetic Tool (SparkDrop): This is a key novel method developed by the authors. SparkDrop allows for the induction of phase separation of N-myc without altering its overall protein expression levels. This is crucial for decoupling the effects of phase separation from the effects of increased protein concentration.
- Fluorescence In Situ Hybridization (FISH): To determine if N-myc condensates localize to specific target gene loci (e.g., p53).
- Immunofluorescence Staining: To assess the presence of transcriptional machinery components (Mediator, RNA polymerase II) and nascent RNA within N-myc condensates.
- RNA Sequencing (RNA-seq): To comprehensively analyze the transcriptome and identify genes regulated by diffuse N-myc versus phase-separated N-myc.
- Quantitative Analysis: Using techniques like HPLC to measure protein concentrations in dilute and dense phases, and image analysis to quantify colocalization and condensate properties.
- In Vitro Experiments: To study the effect of DNA binding on N-myc phase separation.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- N-myc Forms Dynamic Condensates: N-myc, particularly in MYCN-amplified cells, forms dynamic, liquid-like condensates in the nucleus above a specific concentration threshold. This phase separation is dependent on the intrinsically disordered transactivation domain (TAD).
- Condensates are Transcriptionally Active: These N-myc condensates recruit its DNA-binding partner MAX, are found at target gene loci (like p53), and contain key components of the transcriptional machinery (Mediator, RNA Pol II) and nascent RNA, indicating they are transcriptionally active assemblies.
- Chemogenetic Control is Key: The development of the SparkDrop system is a significant contribution, allowing researchers to induce phase separation without changing protein levels. This is critical for isolating the specific effects of phase separation.
- Phase Separation Modulates a Small Subset of Genes: While N-myc condensates are transcriptionally active, they only differentially regulate a small fraction (<3%) of N-myc-responsive genes. This suggests that diffuse N-myc complexes are largely sufficient for broad transcriptional regulation.
- Differential Regulation of Oncogenes and Tumor Suppressors: The genes that are differentially regulated by phase separation are enriched for oncogenes (e.g., C3, SERINC2) and tumor suppressors (e.g., RGMA, MALAT1), suggesting a specific role in promoting oncogenesis.
- Mitotic Regulation: N-myc condensates dynamically disassemble during mitosis and re-assemble upon exiting mitosis, correlating with chromatin condensation and decondensation.
Key Results
- N-myc forms liquid-like condensates that fuse and coalesce, exhibiting hallmarks of biomolecular condensates.
- The transactivation domain (TAD) of N-myc is essential for its phase separation.
- N-myc condensates colocalize with MAX, Mediator, RNA Pol II S5p, and nascent RNA with high percentages (e.g., ~92% with MAX, ~72% with Pol II S5p).
- The SparkDrop system successfully induced N-myc phase separation without altering protein levels, and these condensates also showed hallmarks of transcriptional activity.
- RNA-seq analysis revealed that diffuse N-myc regulates ~6900 genes, while phase-separated N-myc (compared to diffuse N-myc at the same protein level) differentially regulates only ~99 genes.
- Of the genes upregulated by N-myc, only <3% are further upregulated by phase separation. Similarly, <1% of N-myc-repressed genes are further repressed by phase separation.
- Phase separation of N-myc led to a ~15% increase in cell survival.
Limitations and Future Work
- Limited Scope of Differential Regulation: The authors acknowledge that the majority (>97%) of N-myc-regulated genes are not affected by phase separation, suggesting that diffuse complexes are sufficient for broad transcriptional control. This implies that the unique functional contribution of phase separation is specific to a small subset of genes.
- Dynamic Nature of Condensates: While N-myc condensates are transcriptionally active, their lifetimes are limited by disassembly during mitosis, which may restrict their long-term impact.
- Future Directions: The authors suggest that the specific subset of genes regulated by phase separation, particularly oncogenes and tumor suppressors, could represent interesting drug targets. Further investigation into the mechanisms by which condensates alter chromatin structure and bring genes into proximity of enhancers could provide deeper insights. Understanding how these emergent properties of condensates contribute to oncogenesis is a key area for future research.
Summary updated